• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 对韩国癌症筛查的影响。

Impact of COVID-19 on cancer screening in South Korea.

机构信息

National Cancer Center, Graduate School of Cancer Science and Policy, 323, Ilsan-ro, Ilsandong-gu, Goyang, Gyeonggi-do, 10408, Korea.

National Cancer Center, National Cancer Control Institute, Goyang, Gyeonggi-do, Korea.

出版信息

Sci Rep. 2022 Jul 5;12(1):11380. doi: 10.1038/s41598-022-15778-3.

DOI:10.1038/s41598-022-15778-3
PMID:35790880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9255521/
Abstract

The coronavirus disease (COVID-19) pandemic significantly declined cancer screening rates worldwide. Its impact on the South Korean population is unclear, depending on socioeconomic status (SES), residence, and history of chronic disease. This study utilized data (2018-2020) from the Korean National Cancer Screening Survey, an annual cross-sectional study employing nationally representative random sampling. Cancer screening rates were defined as the proportion of the eligible population who received respective cancer screening within the last 1 year and investigated four major cancers (stomach, colorectal, breast, and cervical). Screening rates every year were compared with screening rate ratios (SRRs) and the corresponding 95% confidence intervals (CIs). Between 2019 and 2020, screening rates declined significantly by 23%, 17%, 12%, and 8% for colorectal cancer (SRR 0.77; 95% CI 0.73-0.82), stomach cancer (SRR 0.83; 95% CI 0.79-0.87), breast cancer (SRR 0.88; 95% CI 0.82-0.93), and cervical cancer (SRR 0.92; 95% CI 0.87-0.97), respectively. Regardless of cancer type, screening was significantly lower in metropolitan residents, those with higher SES, and, interestingly, those without a history of chronic diseases. The significant decline in cancer screening during the pandemic requires urgent political intervention to reduce the burden of future cancer incidence and mortality.

摘要

冠状病毒病(COVID-19)大流行导致全球癌症筛查率显著下降。其对韩国人口的影响尚不清楚,这取决于社会经济地位(SES)、居住地和慢性病史。本研究利用了韩国国家癌症筛查调查(2018-2020 年)的数据,该调查是一项采用全国代表性随机抽样的年度横断面研究。癌症筛查率被定义为在过去 1 年内接受相应癌症筛查的合格人群比例,并调查了四种主要癌症(胃癌、结直肠癌、乳腺癌和宫颈癌)。每年的筛查率与筛查率比(SRR)及其相应的 95%置信区间(CI)进行了比较。2019 年至 2020 年,结直肠癌(SRR 0.77;95%CI 0.73-0.82)、胃癌(SRR 0.83;95%CI 0.79-0.87)、乳腺癌(SRR 0.88;95%CI 0.82-0.93)和宫颈癌(SRR 0.92;95%CI 0.87-0.97)的筛查率分别显著下降了 23%、17%、12%和 8%。无论癌症类型如何,大都市居民、SES 较高者以及有趣的是,没有慢性病史者的筛查率均明显较低。大流行期间癌症筛查的显著下降需要紧急的政治干预,以减轻未来癌症发病率和死亡率的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa5/9256672/206a3f8c7277/41598_2022_15778_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa5/9256672/206a3f8c7277/41598_2022_15778_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa5/9256672/206a3f8c7277/41598_2022_15778_Fig1_HTML.jpg

相似文献

1
Impact of COVID-19 on cancer screening in South Korea.COVID-19 对韩国癌症筛查的影响。
Sci Rep. 2022 Jul 5;12(1):11380. doi: 10.1038/s41598-022-15778-3.
2
Changes in cancer screening before and during COVID-19: findings from the Korean National Cancer Screening Survey 2019 and 2020.癌症筛查在 COVID-19 前后的变化:来自 2019 年和 2020 年韩国国家癌症筛查调查的结果。
Epidemiol Health. 2022;44:e2022051. doi: 10.4178/epih.e2022051. Epub 2022 May 30.
3
The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.COVID-19 对韩国结直肠癌、胃癌、乳腺癌和宫颈癌筛查的影响。
Epidemiol Health. 2022;44:e2022053. doi: 10.4178/epih.e2022053. Epub 2022 Jun 21.
4
Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005-2020.韩国女性宫颈癌筛查率的趋势:韩国国家癌症筛查调查结果,2005-2020 年。
J Gynecol Oncol. 2022 Jul;33(4):e39. doi: 10.3802/jgo.2022.33.e39. Epub 2022 Feb 11.
5
Impact of the Australian National Cervical Screening Program in women of different ages.澳大利亚国家宫颈癌筛查计划对不同年龄女性的影响。
Med J Aust. 2016 Oct 17;205(8):359-364. doi: 10.5694/mja16.00289.
6
Socioeconomic Inequalities in Cervical and Breast Cancer Screening among Women in Korea, 2005-2015.2005 - 2015年韩国女性宫颈癌和乳腺癌筛查中的社会经济不平等现象
Yonsei Med J. 2018 Nov;59(9):1026-1033. doi: 10.3349/ymj.2018.59.9.1026.
7
Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey.2011年韩国癌症筛查状况:韩国全国癌症筛查调查结果
Asian Pac J Cancer Prev. 2012;13(4):1187-91. doi: 10.7314/apjcp.2012.13.4.1187.
8
Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.韩国的宫颈癌筛查:2008年国家癌症筛查计划报告。
Asian Pac J Cancer Prev. 2011;12(8):1961-4.
9
Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009.韩国人群中糖尿病患者的癌症筛查率:来自2007 - 2009年韩国国家健康与营养检查调查的结果
Epidemiol Health. 2017 Aug 10;39:e2017036. doi: 10.4178/epih.e2017036. eCollection 2017.
10
Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013.韩国男性和女性癌症筛查率的趋势:2004 - 2013年韩国全国癌症筛查调查结果
Cancer Res Treat. 2016 Jan;48(1):1-10. doi: 10.4143/crt.2014.204. Epub 2015 Apr 15.

引用本文的文献

1
Trends in socioeconomic inequalities in cancer screening participation before and after the COVID-19 pandemic in Japan.日本新冠疫情前后癌症筛查参与方面的社会经济不平等趋势。
J Epidemiol. 2025 May 17;35(10):451-9. doi: 10.2188/jea.JE20250021.
2
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2022.韩国癌症统计数据:2022年的发病率、死亡率、生存率和患病率
Cancer Res Treat. 2025 Apr;57(2):312-330. doi: 10.4143/crt.2025.264. Epub 2025 Mar 11.
3
Changes in the Percentage of Patients Treated for Cancer Before and After the SARS-CoV-2 Epidemic: A Retrospective Observational Study.

本文引用的文献

1
Assessment of the fear of COVID-19 and its impact on lung cancer screening participation among the Korean general population.韩国普通人群对新冠病毒的恐惧及其对肺癌筛查参与度的影响评估。
Transl Lung Cancer Res. 2021 Dec;10(12):4403-4413. doi: 10.21037/tlcr-21-746.
2
Impact of the COVID-19 Pandemic on the Diagnosis and Surgery of Breast Cancer: A Multi-Institutional Study.新冠疫情对乳腺癌诊断与手术的影响:一项多机构研究
J Breast Cancer. 2021 Dec;24(6):491-503. doi: 10.4048/jbc.2021.24.e55.
3
Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemic.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情前后癌症治疗患者百分比的变化:一项回顾性观察研究。
Juntendo Iji Zasshi. 2024 Dec 31;70(6):445-452. doi: 10.14789/ejmj.JMJ24-0015-OA. eCollection 2024.
4
The Association of the COVID-19 Pandemic with the Uptake of Colorectal Cancer Screening Varies by Socioeconomic Status in Flanders, Belgium.在比利时弗拉芒地区,新冠疫情与结直肠癌筛查的接受情况之间的关联因社会经济地位而异。
Cancers (Basel). 2024 Nov 27;16(23):3983. doi: 10.3390/cancers16233983.
5
Determinants of Prostate Cancer Screening in Korean Men: A Nationwide Study Using the Korean National Cancer Screening Survey 2023.韩国男性前列腺癌筛查的决定因素:一项基于2023年韩国国家癌症筛查调查的全国性研究
Cancer Res Treat. 2025 Apr;57(2):539-546. doi: 10.4143/crt.2024.879. Epub 2024 Oct 29.
6
Prevalence of Breast Cancer Screening in Asia: Systematic Review and Meta-Analysis.亚洲地区乳腺癌筛查的流行率:系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3379-3391. doi: 10.31557/APJCP.2024.25.10.3379.
7
Resilience Gap in Gastrointestinal Endoscopy Activity during the COVID-19 Pandemic in South Korea.韩国新冠疫情期间胃肠内镜检查活动中的恢复力差距
Chonnam Med J. 2024 Sep;60(3):180-186. doi: 10.4068/cmj.2024.60.3.180. Epub 2024 Sep 25.
8
Impact of Coronavirus Disease 2019 on the Diagnosis and Treatment of Pancreatic Cancer: An Observational Cohort Study.2019年冠状病毒病对胰腺癌诊断和治疗的影响:一项观察性队列研究
Turk J Gastroenterol. 2024 Feb 7;35(5):408-417. doi: 10.5152/tjg.2024.23563.
9
Towards AI-Driven Healthcare: Systematic Optimization, Linguistic Analysis, and Clinicians' Evaluation of Large Language Models for Smoking Cessation Interventions.迈向人工智能驱动的医疗保健:大型语言模型在戒烟干预中的系统优化、语言分析及临床医生评估
Proc SIGCHI Conf Hum Factor Comput Syst. 2024 May;2024. doi: 10.1145/3613904.3641965. Epub 2024 May 11.
10
Association between Endoscopist Volume and Interval Cancers after Colonoscopy: Results from the National Colorectal Cancer Screening Program in Korea.内镜医师工作量与结肠镜检查后间期癌症的关系:来自韩国国家结直肠癌筛查计划的结果。
Cancer Res Treat. 2024 Oct;56(4):1164-1170. doi: 10.4143/crt.2024.009. Epub 2024 Apr 16.
COVID-19 大流行期间 32 家社区卫生中心乳腺癌筛查率的变化。
Cancer. 2021 Dec 1;127(23):4512-4515. doi: 10.1002/cncr.33859. Epub 2021 Aug 26.
4
Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.测量 COVID-19 大流行对加拿大安大略省有组织的癌症筛查和诊断随访护理的影响:一项省级、基于人群的研究。
Prev Med. 2021 Oct;151:106586. doi: 10.1016/j.ypmed.2021.106586.
5
COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.2020 年 1 月至 6 月,美国全国乳腺癌和宫颈癌早期检测计划(NBCCEDP)中 COVID-19 对筛查检测量的影响。
Prev Med. 2021 Oct;151:106559. doi: 10.1016/j.ypmed.2021.106559. Epub 2021 Jun 30.
6
Socioeconomic and Racial Inequities in Breast Cancer Screening During the COVID-19 Pandemic in Washington State.华盛顿州新冠疫情期间乳腺癌筛查中的社会经济和种族不平等现象
JAMA Netw Open. 2021 May 3;4(5):e2110946. doi: 10.1001/jamanetworkopen.2021.10946.
7
Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.美国癌症筛查不足与新冠疫情的关联。
JAMA Oncol. 2021 Jun 1;7(6):878-884. doi: 10.1001/jamaoncol.2021.0884.
8
Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States.美国女性在符合 USPSTF 乳腺癌、宫颈癌和结直肠癌筛查指南方面的差异。
Prev Chronic Dis. 2021 Apr 15;18:E37. doi: 10.5888/pcd18.200315.
9
Assessment of Fear of COVID-19 in Older Adults: Validation of the Fear of COVID-19 Scale.老年人对新冠病毒恐惧的评估:新冠病毒恐惧量表的验证
Int J Ment Health Addict. 2022;20(2):1231-1245. doi: 10.1007/s11469-020-00438-2. Epub 2021 Jan 6.
10
Race and ethnicity, gender, and age on perceived threats and fear of COVID-19: Evidence from two national data sources.种族与族裔、性别及年龄对新冠疫情感知威胁和恐惧的影响:来自两个全国性数据源的证据
SSM Popul Health. 2021 Mar;13:100717. doi: 10.1016/j.ssmph.2020.100717. Epub 2020 Dec 13.